Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-230,000
Closed -$2.57M 166
2023
Q4
$2.57M Buy
230,000
+163,669
+247% +$1.5M 0.06% 340
2023
Q3
$1.02M Sell
66,331
-28,368
-30% -$476K 0.02% 432
2023
Q2
$1.79M Buy
94,699
+79,957
+542% +$1.4M 0.04% 482
2023
Q1
$225K Buy
+14,742
New +$192K 0.01% 585

Other funds holding ETNB

Weiss Multi-Strategy Advisers's ETNB Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of 89bio (ETNB) in Q1 2024, closing a stake of 230,000 shares — an estimated $2.57M sold.

Weiss Multi-Strategy Advisers first reported a position in ETNB in Q1 2023 and held it in 4 quarters. The position peaked at $2.57M in Q4 2023. 150 funds tracked by Wall St. Rank hold ETNB as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining 89bio position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 230,000 89bio shares in Q1 2024, an estimated $2.57M.
  • Weiss Multi-Strategy Advisers first reported a position in 89bio in Q1 2023 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's 89bio position peaked at $2.57M in Q4 2023.
  • 150 funds tracked by Wall St. Rank held 89bio as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.